InvestorsHub Logo
Followers 3819
Posts 239379
Boards Moderated 0
Alias Born 07/30/2007

Re: lasernat post# 1673444

Thursday, 05/26/2016 3:47:13 PM

Thursday, May 26, 2016 3:47:13 PM

Post# of 2338822
BSSP .0002 Must read (IPF) DD on the company by stervc ~
Regarding this awesome key BSSP Update...

Thanks for confirming from Mrs. Diana Zhabilov that the deal between BSSP/Canteck Pharma, Inc. is already done and that they are waiting for a couple minor things that needs completed. Mrs. Diana Zhabilov has extensive medial based qualifications and certifications and is listed to be the new Chairman and President of the new company while also being listed as a Director of the new company too. So she would know. Her saying that the deal is done is fair to believe that the deal is done.

With the TV show Dr. Oz, I did research that piece that you mentioned about their Immunotherapy with their Irreversible Pepsin Fraction (IPF) specific to the Cancer indication product and treatment programs being on the Dr. Oz television show to also be true.

I also learned that publicly on the Dr. Oz TV show, Mehmet Cengiz Oz (also known as “Dr. Oz”) and Dr. Otis Brawley from the American Cancer Society had given their Immunotherapy lots of praise worldwide as a revolutionary and growing style of treatments to use worldwide for HIV, Cancer, Hepatitis and Aids. After doing a little research, I learned that they both spoke very highly about this patented technology that now belongs to BSSP/Canteck Pharma, Inc. The primary speaker on the show representing the company’s technology was Mr. Harry Zhabilov Jr. BSc, McS Science who is the Chief Scientist of this new company and is responsible for the development of the Patented Technology and various applications including the platform for the IPF.

v/r
Sterling
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=122496935 .

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.